The clinical significance of occult hepatitis B transfusion in Taiwan – a look‐back study

Objectives: A look‐back study was conducted to determine the clinical significance of occult hepatitis B virus (HBV) blood transfusion in an HBV hyperendemic area.

[1]  Lei Li,et al.  The efficacy of individual‐donation and minipool testing to detect low‐level hepatitis B virus DNA in Taiwan , 2010, Transfusion.

[2]  J. Allain,et al.  Transfusion-transmitted hepatitis B virus infection. , 2009, Journal of hepatology.

[3]  M. Buendia,et al.  Statements from the Taormina expert meeting on occult hepatitis B virus infection. , 2008, Journal of hepatology.

[4]  Lei Li,et al.  A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus , 2008, Transfusion.

[5]  F. Hollinger.  Hepatitis B virus infection and transfusion medicine: science and the occult , 2008, Transfusion.

[6]  E. Vamvakas,et al.  Hepatitis B virus DNA–positive, hepatitis B surface antigen–negative blood donations intercepted by anti‐hepatitis B core antigen testing: the Canadian Blood Services experience , 2007, Transfusion.

[7]  M. Satake,et al.  Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program , 2007, Transfusion.

[8]  Ding‐Shinn Chen,et al.  Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  J. Allain.  Occult hepatitis B virus infection and transfusion. , 2006, Journal of Hepatology.

[10]  Ding‐Shinn Chen,et al.  Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. , 2004, Journal of hepatology.

[11]  J. Allain,et al.  Occult hepatitis B virus infection: implications in transfusion , 2004, Vox sanguinis.

[12]  Ding‐Shinn Chen,et al.  Transfusion‐transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers , 2002, Transfusion.

[13]  Ding‐Shinn Chen,et al.  Occult Hepatitis B Virus Infection and Clinical Outcomes of Patients with Chronic Hepatitis C , 2002, Journal of Clinical Microbiology.

[14]  Ding‐Shinn Chen,et al.  Sequence analysis of pre‐S/surface and pre‐core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection , 2002, Journal of medical virology.

[15]  R. Tedder,et al.  Evidence that anti‐HBc but not HBV DNA testing may prevent some HBV transmission by transfusion , 1999, British journal of haematology.

[16]  M. Lai,et al.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.

[17]  R. Gupta,et al.  Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. , 1996, Journal of hepatology.

[18]  L. Ferrell,et al.  "Occult" hepatitis B virus as source of infection in liver transplant recipients , 1994, The Lancet.

[19]  J. Sung,et al.  A prospective study of posttransfusion hepatitis in Taiwan. , 1991, Journal of hepatology.

[20]  H. Ullum,et al.  HBsAg non‐reactive HBV infection in blood donors: Transmission and pathogenicity , 2007 .

[21]  Chien-Hung Chen,et al.  Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. , 2007, Journal of the Formosan Medical Association = Taiwan yi zhi.

[22]  Ding‐Shinn Chen,et al.  Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. , 2006, Journal of hepatology.

[23]  S. Nick,et al.  Evaluation of 17 CE‐marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection , 2006, Journal of medical virology.